A One-Two Punch

Tayyaba Hasan and her colleagues developed nanocells that "combine light-based therapy with molecules" to stop cancer cells growth by limiting their supply of oxygen, reports MIT's Technology Review. The researchers enclosed the photosensitive drug verteporfin the solid polymer nanoparticles which were then, in turn, closed up in lipid particles that also contained bevacizumab, a drug that prevent blood vessel growth. The team then tested the nanocells in mice with pancreatic tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.